久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Azurity Pharmaceuticals Completes Acquisition of Covis Pharma PR Newswire
    March 14, 2025
    Azurity announced today the successful completion of its acquisition of Covis from existing investors.
  • AZ sells respiratory trio to Covis pharmatimes
    November 09, 2018
    Covis currently sells Alvesco, Omnaris and Zetonna in the US and will become the owner of the medicines. In return, it will pay AstraZeneca $350 million upon closing.
  • Sunovion Divests Asthma and Allergy Products to Covis americanpharmaceuticalreview
    July 18, 2017
    Sunovion?has entered into a definitive agreement to divest the U.S. market rights to Sunovion’s ciclesonide products ALVESCO Inhalation Aerosol, OMNARIS Nasal Spray, and ZETONNA Nasal Aerosol to Covis Pharma. Ciclesonides are included in the corticosteroi
PharmaSources Customer Service